Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Azher Iqbal

Vascular & Interventional Radiology Buffalo, NY Medical Doctor

NPI 1467476291 CMS profile 65982

100 High St, Buffalo, NY 14203

Open in the dashboard

General payments

$58,233

245 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Azher Iqbal of Buffalo, NY is reported in the CMS Open Payments database as having received $58,233 across 245 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,359 26
2024 General $1,388 25
2023 General $9,662 70
2022 General $6,660 34
2021 General $908 24
2020 General $339 14
2019 General $5,917 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Azher Iqbal
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Azher Iqbal were reported at $33,359. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Azher Iqbal Vascular & Interventional Radiology median Middle half National median
2019 $5,917 $422 $125–$1,555 $163
2020 $339 $200 $68–$652 $114
2021 $908 $280 $99–$866 $132
2022 $6,660 $433 $137–$1,497 $149
2023 $9,662 $506 $152–$2,019 $160
2024 $1,388 $556 $175–$1,930 $164
2025 $33,359 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ConvaTec Inc. $32,915 14 payments
  2. AngioDynamics, Inc. $12,181 27 payments
  3. Philips Electronics North America Corporation $3,645 37 payments
  4. Medtronic, Inc. $2,912 69 payments
  5. Boston Scientific Corporation $2,459 21 payments
  6. Okami Medical, Inc. $438 8 payments
  7. Inari Medical, Inc. $434 4 payments
  8. Cardiovascular Systems Inc. $413 8 payments
  9. Medtronic USA, Inc. $308 3 payments
  10. Penumbra, Inc. $269 2 payments
  11. Other $2,260 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Debt forgiveness $32,800 13 payments
  2. Food and Beverage $10,964 214 payments
  3. Long term medical supply or device loan $9,708 2 payments
  4. Travel and Lodging $4,761 16 payments
Products named General payments · program years 2019–2025
  1. INNOVAMATRIX AC $32,915 14 payments
  2. Auryon Laser System 100-120 Vac Et $9,913 3 payments
  3. IGT D Peripheral $2,828 20 payments
  4. AURYON LASER SYSTEM 100-120 VAC Pad $2,215 21 payments
  5. DIREXION $1,446 7 payments
  6. ELLIPSYS VASCULAR ACCESS SYSTEM $1,299 27 payments
  7. Abre $631 10 payments
  8. LOBO $438 8 payments
  9. CT THROMBECTOMY SYSTEM KIT $371 3 payments
  10. FLOWTRIEVER CATHETER, S $371 3 payments
  11. Other $6,474 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$379,972

Of which drugs: $49,788

Medicare patients

181

Average age 73

Services billed

5,414

90 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Chronic kidney disease 52%
Ischemic heart disease 46%
Diabetes 39%
Heart failure 37%
Atrial fibrillation 32%
COPD 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml Q9965 Office 41 4,742 $4,204

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

245 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record